deferiprone has been researched along with didanosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Georgiou, NA; Marx, JJ; Nottet, HS; Oudshoorn, M; van Asbeck, BS; van der Bruggen, T | 1 |
2 other study(ies) available for deferiprone and didanosine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin.
Topics: Anti-HIV Agents; Bleomycin; Cytotoxicity, Immunologic; Deferiprone; Deferoxamine; Didanosine; Drug Synergism; HIV Core Protein p24; HIV-1; Humans; Iron Chelating Agents; Leukocytes, Mononuclear; Lymphocyte Activation; Lymphocytes; Macrophages; Monocytes; Pyridones; Virus Replication | 2000 |